|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Three-dimensional imaging improves surgical performance for both novice and experienced operators using the da Vinci Robot System显示文摘 | John C. Byrn Stefanie Schluender Celia M. Divino John Conrad Brooke Gurland Edward Shlasko Amir Szold | 2007 | The American Journal of Surgery2007，，4： | 3 |
| 2 | Mycoplasma pneumoniae in children with acute and refractory asthma显示文摘 | Pamela R. Wood Vanessa L. Hill Margaret L. Burks Jay I. Peters Harjinder Singh Thirumalai R. Kannan Shruthi Vale Marianna P. Cagle Molly F.R. Principe Joel B. Baseman Edward G. Brooks | 2013 | Annals of Allergy Asthma & Immunology2013，，5： | 2 |
| 3 | Utility of liver biopsy in predicting clinical outcomes after percutaneous angioplasty for hepatic venous obstruction in liver transplant patients显示文摘AIM: To determine utility of transplant liver biopsy in evaluating efficacy of percutaneous transluminal angioplasty(PTA) for hepatic venous obstruction(HVOO). METHODS: Adult liver transplant patients treated with PTA for HVOO(2003-2013) at a single institution were reviewed for pre/post-PTA imaging findings, manometry(gradient with right atrium), presence of HVOO on prePTA and post-PTA early and late biopsy(EB and LB, < or > 60 d after PTA), and clinical outcome, defined as good(no clinical issues, non-HVOO-related death) or poor(surgical correction, recurrent HVOO, or HVOOrelated death). RESULTS: Fifteen patients meeting inclusion criteria underwent 21 PTA, 658 ± 1293 d after transplant.In procedures with pre-PTA biopsy(n = 19), no difference was seen between pre-PTA gradient in 13/19 procedures with HVOO on biopsy and 6/19 procedures without HVOO(8 ± 2.4 mm Hg vs 6.8 ± 4.3 mm Hg; P = 0.35). Post-PTA, 10/21 livers had EB(29 ± 21 d) and 9/21 livers had LB(153 ± 81 d). On clinical follow-up(392 ± 773 d), HVOO on LB resulted in poor outcomes and absence of HVOO on LB resulted good outcomes. Patients with HVOO on EB(3/7 good, 4/7 poor) and no HVOO on EB(2/3 good, 1/3 poor) had mixed outcomes. CONCLUSION: Negative liver biopsy greater than 60 d after PTA accurately identifies patients with good clinical outcomes. | Ammar Sarwar Edward Ahn Ian Brennan Olga R Brook Salomao Faintuch Raza Malik Khalid Khwaja Muneeb Ahmed | 2015 | World Journal of Hepatology2015，7，14： | 2 |
| 4 | Combined Heart and Liver Transplantation: A Single-Center Experience显示文摘 | Eugenia Raichlin Richard C. Daly Charles B. Rosen Christopher G. McGregor Michael R. Charlton Robert P. Frantz Alfredo L. Clavell Richard J. Rodeheffer Naveen L. Pereira Walter K. Kremers Sudhir S. Kushwaha Brooks S. Edwards | 2009 | Transplantation2009，，2： | 1 |
| 5 | Dermoid cyst of the orbit and frontal sinus:A case report显示文摘 | Nguyen Si P Arthur Brooks D Edward Bradley S | | 0，，04： | 1 |
| 6 | Three-dimensional imaging improves surgical performance for both novice and experienced operators using the da Vinci Robot System显示文摘 | John C. Byrn Stefanie Schluender Celia M. Divino John Conrad Brooke Gurland Edward Shlasko Amir Szold | 2007 | The American Journal of Surgery2007，，4： | 1 |
| 7 | 糖尿病视网膜病变和黄斑囊样水肿患者曲安奈德眼内注射前、后玻璃体内血管内皮生长因子和基质衍生因子-1的水平显示文摘背景:能导致糖尿病视网膜病变(DR)视力丧失的弥漫性黄斑囊样水肿(DME)和(或)异常新生血管(NV)可能受生长因子和化学激活剂的调节。化学激活素基质衍生因子-1(SDF-1)是一种血管内皮生长因子(VEGF)表达的有效刺激剂,是NV的重要效应物。并且是与发生DME有关血管通透性的关键诱导物。循环中的内皮前体细胞对SDF-1应答迁徙参与NV。目的:调查不同程度的的DR和DME患者。在眼内注射曲安奈德(triamcinolone acetonide)前后,玻璃体中SDF-1和VEGF之间的关系。用于治疗难治的DME。方法:在这一前瞻性的研究中。包括36例患者并观察了6个月。在紧接着注射曲安奈德前和注射1个月后获得的标本,用酶联免疫吸附试验检测玻璃体中VEGF和SDF-1的水平。结果:增生性DR患者的VEGF和SDF-1与非增生DR患者相比显著高(P〈0.01)。DME患者与非DME患者相比较。SDF-1水平显著增加。VEGF与SDF-1的水平和疾病的严重程度相关(r^2=0.88)。结论:应用曲安奈德出现了激动人心的结果,VEGF和SDF-1降到了几乎检测不出来的水平。消除了DME并使活动性的NV退化。我们的结果支持SDF-1和VEGF在DR有害视力后果的发病机制中的作用,并提示注射曲安奈德后,可能由于抑制了VEGF和SDF-1,使得DME消退和(或)NV开始纤维化的退化。 | H. Logan Brooks Sergio Caballero Charles K. Newell Robert L. Steinmetz Debbie Watson Mark S. Segal Jeffrey K. Harrison Edward W. Scott Maria B. Grant 孙文赏(译) 申敏如(校) | 2005 | 美国医学会眼科杂志(中文版)2005，17，2： | 1 |
| 8 | Cardiac Transplantation for Radiation-Induced Cardiomyopathy: The Mayo Clinic Experience显示文摘 | Pankaj Saxena Lyle D. Joyce Richard C. Daly Sudhir S. Kushwaha John A. Schirger Jordan Rosedahl Joseph A. Dearani Tomas Kara Brooks S. Edwards | 2014 | The Annals of Thoracic Surgery2014，，6： | 1 |
| 9 | Exercise-induced activation of the branched-chain 2-oxo acid dehydrogenase in human muscle显示文摘 | Anton J. M. Wagenmakers John H. Brookes John H. Coakley Thomas Reilly Richard H. T. Edwards | 1989 | European Journal of Applied Physiology and Occupational Physiology1989，，3： | 1 |
| 10 | Ethnic differences in inflammatory bowel disease: Results from the United Kingdom inception cohort epidemiology study显示文摘BACKGROUND The current epidemiology of inflammatory bowel disease(IBD)in the multiethnic United Kingdom is unknown.The last incidence study in the United Kingdom was carried out over 20 years ago.AIM To describe the incidence and phenotype of IBD and distribution within ethnic groups.METHODS Adult patients(>16 years)with newly diagnosed IBD(fulfilling Copenhagen diagnostic criteria)were prospectively recruited over one year in 5 urban catchment areas with high South Asian population.Patient demographics,ethnic codes,disease phenotype(Montreal classification),disease activity and treatment within 3 months of diagnosis were recorded onto the Epicom database.RESULTS Across a population of 2271406 adults,339 adult patients were diagnosed with IBD over one year:218 with ulcerative colitis(UC,64.3%),115 with Crohn's disease(CD,33.9%)and 6 with IBD unclassified(1.8%).The crude incidence of IBD,UC and CD was 17.0/100000,11.3/100000 and 5.3/100000 respectively.The age adjusted incidence of IBD and UC were significantly higher in the Indian group(25.2/100000 and 20.5/100000)compared to White European(14.9/100000,P=0.009 and 8.2/100000,P<0.001)and Pakistani groups(14.9/100000,P=0.001 and 11.2/100000,P=0.007).The Indian group were significantly more likely to have extensive disease than White Europeans(52.7%vs 41.7%,P=0.031).There was no significant difference in time to diagnosis,disease activity and treatment.CONCLUSION This is the only prospective study to report the incidence of IBD in an ethnically diverse United Kingdom population.The Indian ethnic group showed the highest age-adjusted incidence of UC(20.5/100000).Further studies on dietary,microbial and metabolic factors that might explain these findings in UC are underway. | Ravi Misra Jimmy Limdi Rachel Cooney Samia Sakuma Matthew Brookes Edward Fogden Sanjeev Pattni Naveen Sharma Tariq Iqbal Pia Munkholm Johan Burisch Naila Arebi | 2019 | World Journal of Gastroenterology2019，25，40： | 1 |
| 11 | Management of women who test positive for high-risk types of human papillomavirus: the HART study显示文摘 | J Cuzick A Szarewski H Cubie G Hulman H Kitchener D Luesley E McGoogan U Menon G Terry R Edwards C Brooks M Desai C Gie L Ho I Jacobs C Pickles P Sasieni | 2003 | The Lancet2003，，9399： | 1 |
| 12 | Treatment outcomes associated with surgery for gallbladder cancer: A 20-year experience显示文摘 | Hiromichi Ito M.D. Evan Matros M.D. David C. Brooks M.D. Robert T. Osteen M.D. Michael J. Zinner M.D. Richard S. Swanson M.D. Stanley W. Ashley M.D. Edward E. Whang M.D | 2004 | Journal of Gastrointestinal Surgery2004，，2： | 1 |
| 13 | Surgical treatment of small bowel cancer: A 20-year single institution experience显示文摘 | Hiromichi Ito M.D. Alexander Perez M.D. David C. Brooks M.D. Robert T. Osteen M.D. Michael J. Zinner M.D. Francis D. Moore M.D. Stanley W. Ashley M.D. Edward E. Whang M.D | 2003 | Journal of Gastrointestinal Surgery2003，，7： | 1 |
| 14 | Thin-filmthermelectric devices with high room-temperature figures of merit 显示文摘 | Pama V Edward S Thomas C Brooks O O | 2001 | Nature2001，413，： | 1 |
| 15 | Long term outcomes of cardiac transplant for immunoglobulin light chain amyloidosis:The Mayo Clinic experience显示文摘AIM: To determine the outcome of orthotopic heart transplantation(OHT) in immunoglobulin light chain(AL) amyloidosis.METHODS: The medical records of patients with AL who underwent orthotopic heart transplantation at the Mayo Clinic in Rochester Minnesota from 1992 to 2011 were reviewed. Patients met at least one of the following at: New York Heart Association class Ⅳ heart failure, ventricular thickness > 15 mm, ejection fraction < 40%. Selection guidelines for heart transplant included age < 60 years, absence of multiple myeloma and significant extra-cardiac organ involvement. Baseline characteristics including age, gender, organinvolvement, and New York Heart Association functional class were recorded. Laboratory data, waiting time until heart transplant, and type of treatment of the underlying plasma cell disorder were recorded. Survival from the time of OHT was calculated using KaplanMeier survival curves. Survival of patients undergoing OHT for AL was compared to that of non-amyloid patients undergoing OHT during the same time period.RESULTS: Twenty-three patients(median age 53 years) with AL received OHT. There were no deaths in the immediate perioperative period. Twenty patients have died post OHT. For the entire cohort, the median overall survival was 3.5 years(95%CI: 1.2, 8.2 years). The 1-year survival post OHT was 77%, the 2-year survival 65%, and the 5-year survival 43%. The 5-year survival for non-amyloid patients undergoing OHT during the same era was 85%. Progressive amyloidosis contributed to death in twelve patients. Of those without evidence of progressive amyloidosis, the cause of death included complications of autologous hematopoietic stem cell transplantation for 3 patients, post-transplant lymphoproliferative disorder for 2 patients; and for the remaining one death was related to each of the following causes: acute rejection; cardiac vasculopathy; metastatic melanoma; myelodysplastic syndrome; and unknown. Eight patients had rejection at a median of 1.8 mo post OHT(range 0.4 to 4.9 mo); only one patient died of rejection. Median survival of seven patients who achieved a complete hematologic response to either chemotherapy or autologous hematopoietic stem cell transplantation was 10.8 years. CONCLUSION: Our data demonstrate that long term survival after heart transplant is feasible in AL patients with limited extra-cardiac involvement who achieve complete hematologic response. | Martha Grogan Morie Gertz Arleigh McCurdy Lindsey Roeker Robert Kyle Sudhir Kushwaha Richard Daly Joseph Dearani Richard Rodeheffer Robert Frantz Martha Lacy Suzanne Hayman Christopher McGregor Brooks Edwards Angela Dispenzieri | 2016 | World Journal of Transplantation2016，6，2： | 1 |
| 16 | The link between default and recovery rate : theory, empirical evidence and implications显示文摘 | Edward I Altman Brooks Brady Andrea Resti and Andrea Sironi | 2005 | The Journal of Business2005，6，： | 1 |
| 17 | Constraints on age, erosion, and uplift of Neogene glacial deposits in the Transantarctic Mountains determined from in situ cosmogenic 10Be and 26Al显示文摘 | Edward J Brook Erik T Brown Mark D Kurz | 1995 | Geology1995，23，12： | 1 |
| 18 | Benign nonampullary duodenal neoplasms显示文摘 | Alexander Perez M.D. John R. Saltzman M.D. David L. Carr-Locke M.D. David C. Brooks M.D. Robert T. Osteen M.D. Michael J. Zinner M.D. Stanley W. Ashley M.D. Edward E. Whang M.D | 2003 | Journal of Gastrointestinal Surgery2003，，4： | 1 |
| 19 | Management of women who test positive for high-risk types of human papillomavirus: the HART study显示文摘 | J Cuzick A Szarewski H Cubie G Hulman H Kitchener D Luesley E McGoogan U Menon G Terry R Edwards C Brooks M Desai C Gie L Ho I Jacobs C Pickles P Sasieni | 2003 | The Lancet2003，，9399： | 1 |
| 20 | Integrating the Unfolding Model and Job Embeddedness Model to Better Understand Voluntary Turnover 显示文摘 | BROOKS C HOLTOM EDWARD J INDERRIEDEN | 2006 | Journal of Material Issues2006，，14： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员